Android app Apple app link

Terns Pharmaceuticals, Inc. (TERN) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$35.48

$2.29 (-6.06%)
Last update: 03:41 AM EST
Day's range
$35
Day's range
$38.35

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
12/10/2025 Jefferies Akash Tewari $70.00 $44.83   56.16%
12/09/2025 Barclays Etzer Darout $56.00 $40.23   39.2%
11/28/2025 Mizuho Securities Graig Suvannavejh $33.00 $28.75   14.78%
11/25/2025 Barclays Etzer Darout $36.00 $28.04   28.39%
11/03/2025 BMO Capital Evan Seigerman $22.00 $14.03   56.81%
11/03/2025 Oppenheimer Jay Olson $24.00 $14.03   71.06%
10/23/2025 JMP Securities Silvan Tuerkcan $15.00 $8.30   80.83%
10/22/2025 Mizuho Securities Graig Suvannavejh $9.00 $8.12   10.84%
10/22/2025 Barclays Etzer Darout $14.00 $7.53   85.92%
12/03/2024 Oppenheimer Jay Olson $20.00 $6.36   214.47%
09/16/2024 BMO Capital Etzer Darout $26.00 $8.96   190.34%
08/21/2024 Mizuho Securities Graig Suvannavejh $10.00 $7.79   28.37%
03/15/2024 BMO Capital Etzer Darout $19.00 $7.20   163.89%
09/27/2022 Goldman Sachs Corinne Jenkins $9.00 $4.92   82.93%

Terns Pharmaceuticals, Inc. FAQ's

Terns Pharmaceuticals, Inc. has been rated by research analysts at Jefferies, Oppenheimer, BMO Capital, Truist Financial, Mizuho Securities, H.C. Wainwright in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.